RYAN THURSTON: Open Payments
NPI 1932752615 · SALEM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 59 payments from 19 companies in 2025. Trend: 2023 $718 · 2024 $681 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $282 |
| PFIZER INC. | 19 | $135 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Novo Nordisk Inc | 3 | $50 |
| Lilly USA, LLC | 3 | $44 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| bioMerieux Inc | 1 | $28 |
| Neuronetics, Inc. | 1 | $23 |
Products named: VRAYLAR, QULIPTA, AIRSUPRA, ELIQUIS, UBRELVY, Wegovy, MOUNJARO, TZIELD.
Industry payments across UT — which companies pay providers there.
